Business Description
Balchem Corp
NAICS : 325998
SIC : 2899
ISIN : US0576652004
Share Class Description:
BCPC: Ordinary SharesTotal Employee Number:
1,379Compare
Compare
Traded in other countries / regions
BCPC.USABL9B.Germany Index Membership
Russell 2000Russell 3000 IPO Date
1986-06-03Description
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.58 | |||||
Interest Coverage | 24.44 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 10.73 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 8.5 | |||||
3-Year FCF Growth Rate | 24.7 | |||||
3-Year Book Growth Rate | 10.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.22 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.59 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.22 | |||||
9-Day RSI | 34.35 | |||||
14-Day RSI | 41.63 | |||||
3-1 Month Momentum % | 13.07 | |||||
6-1 Month Momentum % | 2.37 | |||||
12-1 Month Momentum % | 10.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.66 | |||||
Quick Ratio | 1.56 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 76.01 | |||||
Days Sales Outstanding | 48.02 | |||||
Days Payable | 33.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.56 | |||||
Dividend Payout Ratio | 0.18 | |||||
3-Year Dividend Growth Rate | 10.6 | |||||
Forward Dividend Yield % | 0.56 | |||||
5-Year Yield-on-Cost % | 0.93 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 3.52 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.3 | |||||
Operating Margin % | 20.42 | |||||
Net Margin % | 15.14 | |||||
EBITDA Margin % | 24.81 | |||||
FCF Margin % | 15.78 | |||||
OCF Margin % | 20.22 | |||||
ROE % | 12.82 | |||||
ROA % | 9.78 | |||||
ROIC % | 11.53 | |||||
3-Year ROIIC % | 169.88 | |||||
ROC (Joel Greenblatt) % | 46.67 | |||||
ROCE % | 14.44 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 33.36 | |||||
Forward PE Ratio | 27.09 | |||||
PE Ratio without NRI | 30.99 | |||||
Shiller PE Ratio | 45.16 | |||||
Price-to-Owner-Earnings | 33.44 | |||||
PEG Ratio | 3.3 | |||||
PS Ratio | 5.07 | |||||
PB Ratio | 4.17 | |||||
Price-to-Tangible-Book | 15.87 | |||||
Price-to-Free-Cash-Flow | 32.08 | |||||
Price-to-Operating-Cash-Flow | 25.03 | |||||
EV-to-EBIT | 24.91 | |||||
EV-to-Forward-EBIT | 27.5 | |||||
EV-to-EBITDA | 20.48 | |||||
EV-to-Forward-EBITDA | 18.97 | |||||
EV-to-Revenue | 5.08 | |||||
EV-to-Forward-Revenue | 4.57 | |||||
EV-to-FCF | 32.19 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 2.05 | |||||
Price-to-DCF (Earnings Based) | 2.09 | |||||
Price-to-DCF (FCF Based) | 2.23 | |||||
Price-to-Median-PS-Value | 1.01 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.34 | |||||
Price-to-Graham-Number | 4.68 | |||||
| Price-to-Net-Current-Asset-Value | 1415.13 | |||||
Earnings Yield (Greenblatt) % | 4.01 | |||||
FCF Yield % | 3.17 | |||||
Forward Rate of Return (Yacktman) % | 11.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BCPC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Balchem Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,085.881 | ||
| EPS (TTM) ($) | 5.09 | ||
| Beta | 0.8034 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.42 | ||
| Volatility % | 20.38 | ||
| 14-Day RSI | 41.63 | ||
| 14-Day ATR ($) | 3.769493 | ||
| 20-Day SMA ($) | 177.125 | ||
| 12-1 Month Momentum % | 10.67 | ||
| 52-Week Range ($) | 139.17 - 183.9 | ||
| Shares Outstanding (Mil) | 31.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Balchem Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Balchem Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-19 11:00 | In 164 days | ||
| Annual report for 2026 | 2027-02-19 | In 163 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-19 | In 163 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-21 11:00 | In 43 days | ||
| Third quarter earnings results for 2026 | 2026-10-21 | In 42 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 11:00 | 162.73 (-0.36%) | ||
| Second quarter earnings results for 2026 | 2026-07-31 | 162.73 (-0.36%) | ||
| General meeting for 2026 | 2026-06-18 08:30 | 164.38 (+0.42%) | ||
| Wells Fargo Industrials Conference | 2026-06-10 | 162.32 (+1.51%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 11:00 | 173.33 (-1.42%) |
Show
Entries
Balchem Corp Frequently Asked Questions
What is Balchem Corp(BCPC)'s stock price today?
The current price of BCPC is $169.82. The 52 week high of BCPC is $183.90 and 52 week low is $139.17.
When is next earnings date of Balchem Corp(BCPC)?
The next earnings date of Balchem Corp(BCPC) is 2026-10-21 Est..
Does Balchem Corp(BCPC) pay dividends? If so, how much?
The Dividend Yield %  of Balchem Corp(BCPC) is 0.56% (As of Today), Highest Dividend Payout Ratio of Balchem Corp(BCPC) was 0.2. The lowest was 0.15. And the median was 0.18. The  Forward Dividend Yield % of Balchem Corp(BCPC) is 0.56%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NAS:BCPC
Conestoga Micro Cap Composite
Bullish
2026 Q2
What the manager wrote
Balchem Corp. (BCPC) develops specialty ingredients for the nutrition, food, and healthcare markets. The stock underperformed despite another quarter of solid financial results as investors focused on the potential for higher costs associated with ongoing macroeconomic uncertainty. However, the fundamentals supporting our investment thesis remain intact, led by BCPC's leadership in niche markets and long history of consistent execution. We believe the company's strong competitive position and the robust demand environment will ultimately strengthen its market share and growth prospects.
Conestoga Micro Cap Composite
Bullish
2026 Q1
What the manager wrote
Balchem Corp. (BCPC) demonstrated strong resilience in the first quarter, with steady growth across its segments and alignment with 'better-for-you' consumer trends. The company reported nearly 17% net income growth, driven by both pricing and favorable mix. In a more uncertain market, investors are drawn to BCPC's ability to compound earnings with relatively low volatility, highlighting the durability of its business model. This positions Balchem favorably for continued performance amidst market fluctuations.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Balchem Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers